![](https://d3ilqtpdwi981i.cloudfront.net/_wzQjZgjWeyqgR8MEHmHCRXFIkU=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/65/32/fd/6532fd49-620c-4104-bae3-0f09b8e71837/thumbnail_ce30b7e0-02f3-4413-9cc1-530c60ce368c.jpg)
- dressing changes,
- epidermal skin substitute,
- grafting,
- healing time,
- infection rate,
- partial thickness burns,
- porcine xenograft,
- resorbable,
- suprathel,
- synthetic,
- workload
: Porcine xenografts have been used successfully in partial thickness burn treatment for many years. Their disappearance from the market led to the search for effective and efficient alternatives. In this article, we examine the synthetic epidermal skin substitute Suprathel as a substitute in the treatment of partial thickness burns. : A systematic review following the PRISMA guidelines has been performed. Sixteen Suprathel and 12 porcine xenograft studies could be included. Advantages and disadvantages between the treatments and the studies' primary endpoints have been investigated qualitatively and quantitatively. : Although Suprathel had a nearly six times larger TBSA in their studies ( < 0.001), it showed a significantly lower necessity for skin grafts ( < 0.001), and we found a significantly lower infection rate ( < 0.001) than in Porcine Xenografts. Nonetheless, no significant differences in the healing time ( = 0.67) and the number of dressing changes until complete wound healing ( = 0.139) could be found. Both products reduced pain to various degrees with the impression of a better performance of Suprathel on a qualitative level. Porcine xenograft was not recommended for donor sites or coverage of sheet-transplanted keratinocytes, while Suprathel was used successfully in both indications. : The investigated parameters indicate that Suprathel to be an effective replacement for porcine xenografts with even lower subsequent treatment rates. Suprathel appears to be usable in an extended range of indications compared to porcine xenograft. Data heterogeneity limited conclusions from the results.